The New Biopharma Talent Market: AI, M&A, and a K-Shaped Recovery

Episode SummaryIn this episode of Real Pharma, hosts Na-Ri Oh and Ian Wendt sit down with Kristiaan Rawlings, Executive Director at EPM Scientific, to unpack what is really happening in the biopharma talent market right now. From the surprising resurgence of market access hiring to the growing influence of AI in recruiting and candidate preparation, this conversation explores the forces reshaping commercial talent strategy in 2026. The group also digs into salary inflation, title compression, M&A-driven hiring shifts, hybrid work expectations, and why communication skills and executive presence may matter more than ever.

What We Cover

Why market access has re-emerged as one of the hottest hiring areas in biopharma

How companies are responding to policy shifts, competition, and launch pressure

What the current K-shaped hiring market means for candidates in high-demand vs. lower-demand functions

Why specialists in forecasting, analytics, and insights may need to broaden their skill sets

How AI is affecting interviews, candidate prep, and recruiting workflows

The continued importance of presentation skills, executive presence, and storytelling

How M&A activity is influencing hiring, retention packages, and future job movement

What’s happening with salary growth, especially at the director, senior director, and VP levels

Why hybrid work is still the norm and fully remote roles remain limited

What candidates should know before making a move in 2026